Epidemiological features of primary glomerular disease in Turkey: a multicenter study by the Turkish Society of Nephrology Glomerular Diseases Working Group
View/ Open
Access
info:eu-repo/semantics/openAccessDate
2020Author
Türkmen, AydınŞumnu, Abdullah
Cebeci, Egemen
Yazıcı, Halil
Eren, Necmi
Seyahi, Nurhan
Dilek, Kamil
Dede, Fatih
Derici, Ülver Boztepe
Ünsal, Abdülkadir
Şahin, Garip
Sipahioǧlu, Murat Hayri
Gok, Mahmut
Tatar, Erhan
Dursun, Belda
Sıpahı, Savaş
Yılmaz, Mürvet
Süleymanlar, Gültekin
Ulu, Sena Memnune
Güngör, Özkan
Kutlay, Sim
Bahçebaşı, Zerrin Bicik
Şahin, Ídris
Kurultak, İlhan
Türkmen, Kültigin
Yılmaz, Zülfikar
Kazancıoğlu, Rümeyza Turan
Çavdar, Caner
Candan, Ferhan
Aydın, Zeki
Oygar, Düriye Deren
Gul, Cuma Bulent
Arici, Mustafa
Paydaş, Saime
Taymez, Dilek Güven
Küçük, Mehmet
Trablus, Sinan
Turgutalp, Kenan
Koç, Leyla
Sezer, Siren
Duranay, Murat
Bardak, Simge
Altıntepe, Lütfullah
Arikan, Izzet Hakki
Azak, Alper
Odabaş, Ali Rıza
Şahin, Gülizar Manga
Ozturk, Savas
Metadata
Show full item recordCitation
Türkmen, A., Şumnu, A., Cebeci, E., Yazıcı, H., Eren, N., Seyahi, N. ve diğerleri. (2020). Epidemiological features of primary glomerular disease in Turkey: a multicenter study by the Turkish Society of Nephrology Glomerular Diseases Working Group. BMC Nephrology, 21(1), 1-11Abstract
Abstract
Background: The largest data on the epidemiology of primary glomerular diseases (PGDs) are obtained from the
databases of countries or centers. Here, we present the extended results of the Primary Glomerular Diseases Study
of the Turkish Society of Nephrology Glomerular Diseases (TSN-GOLD) Working Group.
Methods: Data of patients who underwent renal biopsy and received the diagnosis of PGD were recorded in the
database prepared for the study. A total of 4399 patients from 47 centers were evaluated between May 2009 and
May 2019. The data obtained at the time of kidney biopsy were analyzed. After the exclusion of patients without
light microscopy and immunofluorescence microscopy findings, a total of 3875 patients were included in the study.
Results: The mean age was 41.5 ± 14.9 years. 1690 patients were female (43.6%) and 2185 (56.3%) were male.
Nephrotic syndrome was the most common biopsy indication (51.7%). This was followed by asymptomatic urinary
abnormalities (18.3%) and nephritic syndrome (17.8%). The most common PGD was IgA nephropathy (25.7%)
followed by membranous nephropathy (25.6%) and focal segmental glomerulosclerosis (21.9%). The mean total
number of glomeruli per biopsy was 17 ± 10. The mean baseline systolic blood pressure was 130 ± 20 mmHg and
diastolic blood pressure was 81 ± 12 mmHg. The median proteinuria, serum creatinine, estimated GFR, and mean
albumin values were 3300 (IQR: 1467–6307) mg/day, 1.0 (IQR: 0.7–1.6) mg/dL, 82.9 (IQR: 47.0–113.0) mL/min and 3.2 ± 0.9 g/dL, respectively.
Conclusions: The distribution of PGDs in Turkey has become similar to that in other European countries. IgA
nephropathy diagnosed via renal biopsy has become more prevalent compared to membranous nephropathy.
Keywords: Epidemiology, Glomerulonephritis, Kidney biopsy, Primary glomerular diseases; the Turkish Society of
Nephrology glomerular diseases (TSN-GOLD) working group, Turkish Society of Nephrology
WoS Q Category
Q3Scopus Q Category
Q2Volume
21Issue
1URI
https://bmcnephrol.biomedcentral.com/track/pdf/10.1186/s12882-020-02134-8.pdfhttps://hdl.handle.net/11468/6954